Sphere Fluidics appoints Dr. Graeme Daniels as Vice President of Sales and Marketing News Sphere Fluidics appoints Dr. Graeme Daniels as Vice President of Sales and Marketing
Sphere Fluidics’ Cyto-Mine® system selected by FairJourney Biologics to advance cell line development workflows News Sphere Fluidics’ Cyto-Mine® system selected by FairJourney Biologics to advance cell line development workflows
Sphere Fluidics expands Cyto-Mine capabilities to meet cGMP requirements for drug manufacture workflows News Sphere Fluidics expands Cyto-Mine capabilities to meet cGMP requirements for drug manufacture workflows
Sphere Fluidics’ Pico-Mine platform chosen by Biosyntia to accelerate synthetic biology and metabolic workflows News Sphere Fluidics’ Pico-Mine platform chosen by Biosyntia to accelerate synthetic biology and metabolic workflows
Sphere Fluidics updates brand identity to align with ambitious, global commercial growth strategy News Sphere Fluidics updates brand identity to align with ambitious, global commercial growth strategy
Sphere Fluidics begins work with partners on 3DSecret program to investigate mechanisms of metastasis in cancer. News Sphere Fluidics begins work with partners on 3DSecret program to investigate mechanisms of metastasis in cancer.
Sphere Fluidics appoints Richard Hammond as Chief Technical Officer News Sphere Fluidics appoints Richard Hammond as Chief Technical Officer
Sphere Fluidics opens new laboratory facilities at Granta Park in Cambridgeshire, UK News Sphere Fluidics opens new laboratory facilities at Granta Park in Cambridgeshire, UK
Sphere Fluidics strengthens commercial team with three new senior hires News Sphere Fluidics strengthens commercial team with three new senior hires
